Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives of Internal Medicine

• Publication date

  2004-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.164.2.190PMID 14744843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antithrombotic treatment in protection against thrombogenic effects of 5-fluorouracil on vascular endothelium: a scanning microscopy evaluation.

  2006cited by this paper
• A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy

  2005cited by this paper
• TNM Atlas : Illustrated Guide to the TNM Classification of Malignant Tumours

  2005cited by this paper
• Tamoxifen and risk of idiopathic venous thromboembolism.

  1998cited by this paper
• The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.

  1998cited by this paper
• Venous thromboembolism and cancer.

  1998cited by this paper
• Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study.

  1997cited by this paper
• Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study

  1997cited by this paper
• Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

  1996cited by this paper
• Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer.

  1996cited by this paper
• The low-probability lung scan. A need for change in nomenclature.

  1995cited by this paper
• Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.

  1994cited by this paper
• Deep venous thrombosis and occult malignancy: an epidemiological study

  1994cited by this paper
• Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma.

  1994cited by this paper
• Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

  1994cited by this paper
• Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.

  1994cited by this paper
• Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

  1992cited by this paper
• Venous thromboembolism and cancer.

  1992cited by this paper
• Influence of cytostatic treatment on the coagulation system and fibrinolysis in patients with non‐Hodgkin's lymphomas and acute leukemias

  1991cited by this paper
• The Incidence and significance of thromboembolic complications in patients with high‐grade gliomas

  1991cited by this paper
• Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.

  1991cited by this paper
• Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).

  1990cited by this paper
• Chemotherapy enhances endothelial cell reactivity to platelets

  1990cited by this paper
• Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels.

  1990cited by this paper
• Thrombogenicity of intravenous 5‐fluorouracil alone or in combination with cisplatin

  1990cited by this paper
• Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

  1990cited by this paper
• Detection of deep-vein thrombosis by real-time B-mode ultrasonography.

  1989cited by this paper
• Prevention of Venous Thromboembolism in General, Surgical Patients: Results of a Meta-Analysis

  1989cited by this paper
• Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5‐fluorouracil

  1989cited by this paper
• Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.

  1988cited by this paper
• Chemotherapy for breast cancer decreases plasma protein C and protein S.

  1988cited by this paper
• The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

  1988cited by this paper
• Prevention of Venous Thromboembolism in General Surgical Patients: Results of Meta‐analysis

  1988cited by this paper
• Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.

  1987cited by this paper
• Endothelial injury caused by antineoplastic agents.

  1986cited by this paper
• Hypercoagulable state induced by cytostatic drugs in stage ii breast cancer patients

  1986cited by this paper
• Promotion of pulmonary metastasis in mice by bleomycin-induced endothelial injury.

  1986cited by this paper
• Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.

  1985cited by this paper
• Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity.

  1985cited by this paper
• Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five‐drug chemotherapy regimen

  1984cited by this paper
• Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy.

  1984cited by this paper
• Renal vascular lesions after chemotherapy with vinblastine, bleomycin, and cisplatin.

  1982cited by this paper
• Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.

  1982cited by this paper
• Venous thrombosis during multimodal treatment of primary breast carcinoma.

  1981cited by this paper
• Pulmonary angiography in acute pulmonary embolism: indications, techniques, and results in 367 patients.

  1971cited by this paper
• Phlegmasia alba dolens.

  year unknowncited by this paper

• Nebivolol rescued the liver and kidney from the coadministration of rivaroxaban and cisplatin by targeting inflammation, oxidative stress, and apoptosis in rats.

  2025cites this paper
• Bleeding risk among cancer patients receiving concurrent CYP-interacting tyrosine kinase inhibitors with direct oral anticoagulants versus alternative anticoagulation therapies.

  2025cites this paper
• Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials

  2025influential citation
• Assessing Morbidity and Malignancy Risk in Patients Presenting with Pulmonary Embolism in an Ambulatory Care Setting

  2025cites this paper
• Cancer genetic profile and risk of thrombosis.

  2025cites this paper
• Lower-extremity deep vein thrombosis induced by oxaliplatin and capecitabine chemotherapy: A case report

  2024cites this paper
• A nomogram to predict the risk of venous thromboembolism in patients with colon cancer in China

  2024cites this paper
• Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.

  2024cites this paper
• The efficacy and safety of direct oral anticoagulants compared with low‐molecular‐weight heparin for venous thromboembolism prophylaxis after surgical resection of primary lower extremity bone or soft‐tissue sarcoma

  2023cites this paper
• Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.

  2023cites this paper
• Efficacy and safety of fondaparinux in preventing venous thromboembolism in Chinese cancer patients: a single-arm, multicenter, retrospective study

  2023cites this paper
• Venous Thromboembolism Risk Assessment in Hospitalized Cancer Patients: A Single Center Study

  2023cites this paper
• Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care

  2023cites this paper
• Risk factors and mortality associated with venous thromboembolism in the elderly US population with acute lymphocytic leukemia

  2023cites this paper
• Venous thromboembolism (VTE) risk assessment in cancer patients receiving chemotherapy in a tertiary care center.

  2022cites this paper
• New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism

  2022cites this paper
• Contemporary breast cancer treatment-associated thrombosis.

  2022cites this paper
• Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER‐Medicare analysis

  2022cites this paper
• Pulmonary embolism associated with oral cancer: A three‐case report and literature review

  2022cites this paper
• Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study

  2022cites this paper
• Markers of hemostasis activation and endothelial damage in patients with active cancer

  2022cites this paper
• Left Upper Lobectomy for Lung Cancer as a Risk Factor for Cerebral Infarction: A Systematic Review and Meta-Analysis

  2021cites this paper
• Early Study of Tumor Abnormal Protein in Gastric Adenocarcinoma

  2021cites this paper
• Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.

  2021cites this paper
• Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

  2021cites this paper
• Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States

  2021cites this paper
• Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer.

  2021cites this paper
• Prevention and treatment of thrombosis in cancer and oncohematological patients

  2021cites this paper
• A Three-Dimensional Microfluidic Device for Monitoring Cancer and Chemotherapy-Associated Platelet Activation

  2021cites this paper
• Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM‐Line): A two‐center open‐label pilot randomized controlled trial

  2021cites this paper
• Assessment of Deep Vein Thrombosis (DVT) incidence among ambulatory cancer patients in Qatar: A retrospective cohort study

  2021cites this paper
• Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer

  2021cites this paper
• Outpatient treatment of emergency department patients diagnosed with venous thromboembolism

  2021cites this paper
• Diagnosis, Treatment, and Prevention of Cancer-Associated Thrombosis

  2020cites this paper
• Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial: January 2020 Annals of Emergency Medicine Journal Club.

  2020cites this paper
• A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer

  2020cites this paper
• Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis

  2020cites this paper
• Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

  2020cites this paper
• Differential biomarker profiles between unprovoked venous thromboembolism and cancer

  2020cites this paper
• [Treatment and secondary prevention of venous thromboembolism in cancer patients].

  2020cites this paper
• Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis.

  2020cites this paper
• Clinical characteristics, management, and outcome of incidental pulmonary embolism in cancer patients.

  2020cites this paper
• Thrombosis prevention and treatment in oncology patients employed in hazardous occupations

  2020cites this paper
• Pharmacological cancer treatment and venous thromboembolism risk

  2020cites this paper
• L’apixaban en thromboprophylaxie pour les patients recevant de la chimiothérapie

  2020cites this paper
• Thrombotic Risk from Chemotherapy and Other Cancer Therapies.

  2019cites this paper
• Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients

  2019cites this paper
• Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

  2019cites this paper
• Thrombosis and Hemostasis in Cancer

  2019cites this paper
• Hodgkin lymphoma, treatment and thrombosis: A dangerous mix.

  2019cites this paper
• A study of clinicopathological characteristics, symptoms and patients experiences related to outcomes in people with cancer and I-PE

  2019cites this paper
• Demographic, clinical, and genetic evaluation of patients with suspected inherited thrombophilia

  2019cites this paper
• Does preoperative pharmacologic prophylaxis reduce the rate of venous thromboembolism in pancreatectomy patients?

  2019cites this paper
• Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials.

  2019cites this paper
• Short-term surgical morbidity and mortality of distal pancreatectomy performed for benign versus malignant diseases: a NSQIP analysis

  2019cites this paper
• Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical Dilemma.

  2019cites this paper
• The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy: A systematic review and meta-analysis of randomized controlled trials.

  2019cites this paper
• Acute arterial thrombosis during adjuvant Adriamycin-cyclophosphamide chemotherapy in a patient with early breast cancer

  2019cites this paper
• Treatment of cancer-related thrombosis: from recommendations to real clinical practice

  2019cites this paper
• Tolérance systémique des injections intravitréennes d’anti-VEGF

  2018cites this paper
• [Systemic safety following intravitreal injections of anti-VEGF].

  2018cites this paper
• Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial.

  2018cites this paper
• Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset

  2018cites this paper
• Risk factors of deep vein thrombosis in cancer patients

  2018cites this paper
• HYPERCOAGULABILITY IN PATIENTS WITH LUNG CANCER UNDERGOING CHEMOTHERAPY

  2018cites this paper
• Risk factors for thrombosis risk in patients with cancer

  2018cites this paper
• Malignancy and Hemostasis

  2018cites this paper
• An analysis of incidental and symptomatic pulmonary embolism (PE) in medical oncology patients

  2017cites this paper
• Prophylactic anticoagulant therapy decreases the incidence of deep vein thrombosis in patients with solid tumors: A systematic review and meta-analysis

  2017cites this paper
• Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

  2017cites this paper
• Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment.

  2017cites this paper
• Risk Assessment Scores for Cancer-Associated Venous Thromboembolic Disease

  2017cites this paper
• Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.

  2017cites this paper
• Czy mikrozatorowość paliczków dystalnych kończyn górnych będąca przyczyną ich martwicy może być spowodowana planową chemioterapią

  2017cites this paper
• Novel insights and developments in thrombosis and haemostasis

  2017cites this paper
• Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions

  2017cites this paper
• Time‐dependent risk and predictors of venous thromboembolism in breast cancer patients: A population‐based cohort study

  2017cites this paper
• Fatal venous embolism in a patient with advanced extramammary Paget disease

  2017influential citation
• Mecanismos do tromboembolismo venoso no câncer: uma revisão da literatura

  2017cites this paper
• Risk of venous thromboembolism in hospitalised cancer patients in England—a cohort study

  2016cites this paper
• Venous thromboembolism in cancer patients: risk assessment, prevention and management.

  2016cites this paper
• Systematic review and meta‐analysis of the risk of severe and life‐threatening thromboembolism in cancer patients receiving anti‐EGFR monoclonal antibodies (cetuximab or panitumumab)

  2016cites this paper
• Targeting Coagulation Mediators in Head and Neck Cancer

  2016cites this paper
• Walker, A.J. and West, Joe and Card, Timothy R. and Humes, David and Grainge, Matthew J. (2014) Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort

  2016cites this paper
• Cancer associated thrombosis: risk factors and outcomes.

  2016cites this paper
• Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.

  2016cites this paper
• Treating patients with cancer and acute venous thromboembolism

  2016cites this paper
• Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients

  2016cites this paper
• Acquired and inherited risk factors for the developing of venous thromboembolism in cancer patients receiving adjuvant chemotherapy: A prospective trial.

  2016cites this paper
• Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

  2016cites this paper
• Can megestrol acetate induce thrombosis in advanced oncology patients receiving chemotherapy?

  2015cites this paper
• Prevention of venous thromboembolism in cancer patients

  2015cites this paper
• Risk Factors of a Pulmonary Thromboembolism After Colorectal Surgery

  2015influential citation
• ТРОМБОЗЫ И ТРОМБОЭМБОЛИИ В ОНКОЛОГИИ. СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМУ

  2015cites this paper
• Risk Factors Associated with Venous Thromboembolism in Cancer Patients

  2015cites this paper
• Venous thromboembolism in patients with cancer undertaking chemotherapy

  2015cites this paper
• Neoadjuvant chemoradiation for rectal cancer is not associated with higher rates of thromboembolism

  2015cites this paper
• Approach to chemotherapy-associated thrombosis

  2015cites this paper
• Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry

  2015cites this paper
• Thromboprophylaxie en médecine palliative : étude d'une cohorte de 312 patients au CHU de Rouen

  2015cites this paper